16
Participants
Start Date
July 17, 2018
Primary Completion Date
July 15, 2019
Study Completion Date
October 15, 2019
Selinexor
"According to escalation level:~* Level -1: Selinexor 40 mg/day, once weekly~* Level 1: Selinexor 60 mg/day, once weekly~* Level 2: Selinexor 80 mg/day, once weekly~* Level 3: Selinexor 100 mg/day, once weekly"
fludarabine
fludarabine 30 mg/m2/day intravenously on days 1 to 4
idarubicin
idarubicin 10 mg/m2/day intravenously on days 1 to 3
cytarabine
cytarabine 2 g/m2/day intravenously on days 1 to 4
G-CSF
G-CSF 300 mcg/m2/day subcutaneously from days -1 to 5
Hospital Germans Tries i Pujol, Badalona, Badalona
Hospital San Pedro de Alcántara,, Cáceres
Hospital Universitario 12 de Octubre,, Madrid
Hospital la Fe, Valencia
PETHEMA Foundation
OTHER